Comparison - TLPPF - OTC PK

Weiss Ratings	TLPPF - OTC PK	Click to Compare	Click to Compare	Click to Compare
Rating	C
Reward Index	Fair
Risk Index	Weak
Risk Grade	D+
Reward Grade	C

Rating Factors	TLPPF - OTC PK	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	Good
Efficiency Index	Fair
Solvency Index	Excellent
Total Return Index	Weak
Volatility Index	Good

Beta / Standard Deviation	TLPPF - OTC PK	Click to Compare	Click to Compare	Click to Compare
Beta	--

Price History	TLPPF - OTC PK	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	-6.13%
30-Day Total Return	-3.72%
60-Day Total Return	10.02%
90-Day Total Return	9.83%
Year to Date Total Return	15.40%
1-Year Total Return	--
2-Year Total Return	--
3-Year Total Return	--
5-Year Total Return	--
52-Week High % Change	-30.58%
52-Week Low % Change	71.64%

Price	TLPPF - OTC PK	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$24.85
52-Week Low Price	$10.05
52-Week Low Price (Date)	May 24, 2024
52-Week High Price (Date)	Feb 24, 2025

Valuation	TLPPF - OTC PK	Click to Compare	Click to Compare	Click to Compare
Market Cap	5.89B
Enterprise Value	5.81B
Price/Earnings (TTM)	179.87
Earnings Per Share (TTM)	0.10
Earnings Per Share Growth	1,069.51%
Price/Earnings To Growth	0.17
Price/Sales (TTM)	11.74
Price/Book (Q)	16.42
Enterprise Value/Revenue (TTM)	11.26
Price	$16.48
Enterprise Value/EBITDA (TTM)	100.77
Enterprise Value/EBIT	107.77
Market Cap Category	Mid Cap

Dividends and Shares	TLPPF - OTC PK	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	351.47M
Dividend Yield	--
Div. Per Share (Most Recent)	--
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	--

Company Info	TLPPF - OTC PK	Click to Compare	Click to Compare	Click to Compare
Phone Number	61 3 9093 3855
Address	55 Flemington Road North Melbourne, VIC 3051
Website	telixpharma.com
Country	Australia
Year Founded	2015

Profitability	TLPPF - OTC PK	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	10.45%
Profit Margin	6.36%

Management Effectiveness	TLPPF - OTC PK	Click to Compare	Click to Compare	Click to Compare
Return on Assets	5.55%
Return on Equity	14.52%

Income Statement	TLPPF - OTC PK	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	516.66M
Total Revenue (TTM)	516.66M
Revenue Per Share	$1.47
Gross Profit (TTM)	319.24M
EBITDA (TTM)	57.74M
EBIT (TTM)	54.00M
Net Income (TTM)	32.91M
Net Income Avl. to Common (TTM)	32.91M
Total Revenue Growth (Q YOY)	48.80%
Earnings Growth (Q YOY)	3.75%
EPS Diluted (TTM)	0.10
EPS Diluted Growth (Q YOY)	-2.59%

Balance Sheet	TLPPF - OTC PK	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	439.60M
Cash Per Share (Q)	$1.25
Total Current Assets (Q)	568.45M
Total Preferred Equity (Q)	--
Total Equity (Q)	351.64M
Current Ratio (Q)	2.776
Book Value Per Share (Q)	$1.05
Total Assets (Q)	938.44M
Total Current Liabilities (Q)	204.79M
Total Debt (Q)	359.83M
Total Liabilities (Q)	586.80M
Total Common Equity (Q)	351.64M

Cash Flow	TLPPF - OTC PK	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	-89.23M
Cash from Financing (TTM)	422.22M
Net Change in Cash (TTM)	387.99M
Levered Free Cash Flow (TTM)	46.47M
Cash from Operations (TTM)	28.36M